15 OTC Markets Issuers Uplist To NASDAQ & NYSE In Q3 2017
Fifteen issuers uplisted from the OTC Markets to the NASDAQ or NYSE in the third quarter of 2017. Only one company uplisted in September. Check out the full OTC Graduate Report from Acquis Capital and see more info about this month’s graduate below:
Fennec Pharmaceuticals Inc. (TSX:FRX), (NASDAQ: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients, left the OTCQB for the NASDAQ Capital Market on September 13, 2017. FENCF raised $7.6 million in June of 2017.